Jul 10, 2025
PhaseV's AI-Powered Trial Optimizer Debuts on AWS Marketplace, Revolutionizing Clinical Trial Design and Efficiency
Jul 01, 2025
Former Moderna Chief Development Officer Melanie Ivarsson OBE Joins PhaseV's Scientific Advisory Board
Jul 01, 2025
PhaseV Announces New ClinOps AI Platform: Transforming Clinical Trial Operations with Precision-Guided Site Selection
May 28, 2025
PhaseV Announces Collaboration with the Crohn's & Colitis Foundation to Advance IBD Research
May 13, 2025
PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients
Apr 22, 2025
PhaseV to Host New Webinar Episode on Patient-Centric Clinical Development
Apr 08, 2025
PhaseV to Present Transformative Use of AI for Clinical Development at Upcoming Events
Mar 24, 2025
PhaseV to Showcase New AI/ML-Powered Clinical Trial Design and Analysis Capabilities at CMO Summit 360
Feb 06, 2025
PhaseV to Present AI Advances in Clinical Development Optimization at Upcoming Biotech and Data Science Events
Feb 03, 2025
PhaseV and Alimentiv Partner on Machine Learning-Based Solution to Tackle Challenges in GI Clinical Trials
Jan 16, 2025
PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration
Dec 12, 2024
PhaseV to Present Novel Causal Machine Learning Method for Understanding Patient Treatment Response at ML4H Symposium
Nov 25, 2024
Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development
Oct 30, 2024
PhaseV Appoints Head of Business Development Amid Growing Demand for its ML-Powered Clinical Trial Optimization Platform
Sep 12, 2024
PhaseV Unveils Machine Learning-Powered Platform to Improve Oncology Clinical Trials
Sep 03, 2024
PhaseV to Present at Upcoming Healthcare, Pharma and Technology Events
Jun 17, 2024
PhaseV Launches New Version of its Machine Learning Platform, Facilitating Increased Adoption of Adaptive Clinical Trials
Apr 25, 2024
PhaseV and Quanticate Partner to Enable Clinical Trial Sponsors to Improve Recruitment, Time to Market and Quality of Studies
Mar 06, 2024
PhaseV and iOMEDICO Partner to Launch New ML-Powered Solution to Increase Success Rates of Phase 3 Oncology Trials